Melanie S Askari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Melanie S Askari has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Beth M Isaac
Bureau of Immunization, New York City Health Department , Long Island City, New York
2 shared publicationsJennifer B Rosen
Bureau of Immunization, New York City Health Department , Long Island City, New York
2 shared publicationsKrishika A Graham
Bureau of Immunization, New York City Health Department , Long Island City, New York
2 shared publications- Robert J. Arciuolo
Bureau of Immunization, New York City Health Department , Long Island City, New York
2 shared publications Antonine Jean
Bureau of Immunization, New York City Health Department , Long Island City, New York
1 shared publication- Hannah K. Gray
Bureau of Immunization, New York City Health Department , Long Island City, New York
1 shared publication
Latest Publications
- 30 October 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Considerations for Assessing Measles Healthcare Facility Exposures
- 30 October 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Considerations for Assessing Measles Healthcare Facility Exposures
- 4 September 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Characterizing Measles Healthcare Facility Exposures—December 2023 Through September 2025: New York City
Background: When people develop measles (cases), healthcare facility exposures are common and result in many potentially exposed people requiring resource-intensive control measures. We summarized exposures and transmission among people exposed to measles (contacts) in healthcare settings in New York City (NYC). Methods: NYC Health Department's surveillance data of NYC contacts exposed to measles cases in any NYC healthcare facility during December 2023–September 2025 were analyzed as a retrospective descriptive study. Characteristics summarized included measles transmission, immunity status, postexposure prophylaxis (PEP) administration, facility setting, and time of measles exposure. Results: Of 2122 healthcare contacts to 28 cases, no secondary cases occurred. 1285 (60.6%) were vaccinated or had other evidence of immunity, 618 (29.1%) were adults with unknown immunity, 124 (5.8%) were not immune and received PEP, and 95 (4.5%) were not immune and did not receive PEP. Most contacts were exposed in emergency departments and/or hospital inpatient settings (1406; 66.3%). Among 1028 contacts with known time of exposure (48.4% of all contacts), 785 (76.4%) overlapped with the case in the healthcare facility, 146 (14.2%) arrived within 1 hour, and 97 (9.4%) arrived 1–2 hours after the case left or were isolated. Conclusions: Most contacts exposed to measles in NYC healthcare facilities had presumptive immunity or were adults with unknown immunity. No transmission occurred among 2122 exposed contacts, including nonimmune contacts. Given no secondary transmission and resource-intensive control measures, relying solely on time-based measles exposure definitions may be overly broad. Incorporating strategies such as facility air exchange data might better assess transmission risk.
- 4 September 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Characterizing Measles Healthcare Facility Exposures—December 2023 Through September 2025: New York City
Background: When people develop measles (cases), healthcare facility exposures are common and result in many potentially exposed people requiring resource-intensive control measures. We summarized exposures and transmission among people exposed to measles (contacts) in healthcare settings in New York City (NYC). Methods: NYC Health Department's surveillance data of NYC contacts exposed to measles cases in any NYC healthcare facility during December 2023–September 2025 were analyzed as a retrospective descriptive study. Characteristics summarized included measles transmission, immunity status, postexposure prophylaxis (PEP) administration, facility setting, and time of measles exposure. Results: Of 2122 healthcare contacts to 28 cases, no secondary cases occurred. 1285 (60.6%) were vaccinated or had other evidence of immunity, 618 (29.1%) were adults with unknown immunity, 124 (5.8%) were not immune and received PEP, and 95 (4.5%) were not immune and did not receive PEP. Most contacts were exposed in emergency departments and/or hospital inpatient settings (1406; 66.3%). Among 1028 contacts with known time of exposure (48.4% of all contacts), 785 (76.4%) overlapped with the case in the healthcare facility, 146 (14.2%) arrived within 1 hour, and 97 (9.4%) arrived 1–2 hours after the case left or were isolated. Conclusions: Most contacts exposed to measles in NYC healthcare facilities had presumptive immunity or were adults with unknown immunity. No transmission occurred among 2122 exposed contacts, including nonimmune contacts. Given no secondary transmission and resource-intensive control measures, relying solely on time-based measles exposure definitions may be overly broad. Incorporating strategies such as facility air exchange data might better assess transmission risk.